Feedback / Questions
Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith
https://www.prnewswire.com/news-releases/helixmith-announces-topline-results-from-phase-2a-study-of-engensis-for-treatment-of-als-amyotrophic-lateral-sclerosis-301617401.html
Sep 6, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next